Three lucky AJP readers have each won one of three 12-month subscriptions to eMIMS
Each single user annual subscription is for eMIMSCloud and the IMGateway drug, herb, food and supplement interactions data base, and is valued at $404.05 per subscription.
Still recommended text by the Pharmacy Board of Australia. The content in eMIMSCloud includes current Australian Product and Consumer Medicine Information, up-to-date PBS restrictions and pricing and a comprehensive evidence-based drug to drug and drug to allergy Interactions database. With additional links to TGA safety bulletins, NPS RADAR and NPS Medicines Update articles; eMIMS is one of MIMS’ richest resources, placing current medicines information, patient care information and clinical tools at your fingertips.
In the new eMIMSCloud you will find additional content such as tools and calculators to help you make decisions based on evidence based parameters.
The three lucky winners are:
Meanwhile, the Society of Hospital Pharmacists of Australia (SHPA) and MIMS have partnered to ensure the 2nd Edition “Don’t Rush to Crush” is available as additional optional content within eMIMS Cloud. Both are included in Pharmacy Board of Australia’s list of essential references for pharmacy practice.
For any healthcare professional prescribing, dispensing or administering medicines understanding what can and cannot be crushed is an imperative. When a tablet or capsule cannot be swallowed, an obvious solution might be to crush the tablet or open the capsule and add the medication to food or drink but many tablets and capsules are not designed to be crushed or opened. For example, crushing an extended release tablet can destroy the medication time release properties with the whole dose being released within a few minutes rather than the intended 12 or 24 hours.
This electronic version of Don’t Rush to Crush contains all updated monographs since the print version was released and updates will continued as and when they are made by the SHPA.
Click here for more information